Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
97,996,626
-
Total 13F shares
-
18,824,963
-
Share change
-
+12,021,646
-
Total reported value
-
$170,928,000
-
Put/Call ratio
-
39%
-
Price per share
-
$9.08
-
Number of holders
-
39
-
Value change
-
+$109,402,310
-
Number of buys
-
31
-
Number of sells
-
8
Institutional Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q3 2021
As of 30 Sep 2021,
aTYR PHARMA INC - COMMON STOCK (ATYR) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,824,963 shares.
The largest 10 holders included
FEDERATED HERMES, INC., FMR LLC, VR Adviser, LLC, TANG CAPITAL MANAGEMENT LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, Ikarian Capital, LLC, TWO SIGMA INVESTMENTS, LP, and TWO SIGMA ADVISERS, LP.
This page lists
39
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.